Metabocure
General Data
Reg Number
517010245
Sector
Medical Devices
Established
2024
No. of Employees
7
Stage
Seed
Additional Funding
1
Description
Metabocure is a biopharmaceutical company focused on developing a pioneering biological drug to address cancer cachexia, a condition characterized by significant body wasting, affecting around 80% and contributing to the demise of approximately 30% o
Technology
MetaboCure is developing a solution that may provide a significant treatment option for cancer patients, suffering from cachexia. The company's drug is designed to preserve metabolic balance in the body, while halting constant nutrient supply to the tumor, starting from the disease's early stages.
Targeted Customers
Oncologists.
Management personnel
Ronen Sarusi - CEO & Co-Founder
Dror Melamed - CTO & President & Co-Founder
Winning details
Route name
Winning year
Startup Fund
Startup Fund
2024